Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 94,143 | 68,887 | 108,419 | 81,698 | 194,494 |
| Marketable Securities | 8,096 | 51,607 | 57,002 | N/A | 34,982 |
| Receivables | 25,543 | 28,896 | 20,773 | 9,670 | N/A |
| Inventories | 3,454 | 3,170 | 2,625 | 2,029 | N/A |
| Other current assets | 3,641 | 477 | 1,787 | 0 | 0 |
| TOTAL | $146,139 | $166,296 | $203,003 | $106,394 | $236,474 |
| Non-Current Assets | |||||
| PPE Net | 2,481 | 3,304 | 3,963 | 4,470 | 5,153 |
| Intangibles | 74,140 | 40,461 | 44,408 | 48,355 | 0 |
| Other Non-Current Assets | 21,460 | 24,844 | 7,748 | 6,306 | 11,163 |
| TOTAL | $98,081 | $68,609 | $56,119 | $59,131 | $16,316 |
| Total Assets | $244,220 | $234,905 | $259,122 | $165,525 | $252,790 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 14,286 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 12,076 | 19,183 | 20,684 | 27,692 | 20,035 |
| Accrued Expenses | 82,318 | 69,030 | 46,431 | 30,648 | 17,426 |
| Other current liabilities | 2,481 | N/A | N/A | N/A | N/A |
| TOTAL | $114,255 | $90,837 | $67,115 | $58,340 | $37,461 |
| Non-Current Liabilities | |||||
| Long Term Debt | 84,025 | 94,962 | 151,886 | 48,477 | N/A |
| Other Non-Current Liabilities | 51,891 | 31,643 | 0 | 0 | 0 |
| TOTAL | $135,916 | $126,605 | $157,701 | $53,883 | $5,505 |
| Total Liabilities | $250,171 | $217,442 | $224,816 | $112,223 | $42,966 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,258 | 39,302 | 38,498 | 37,720 | 36,952 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -1,337,631 | -1,277,636 | -1,202,041 | -1,088,466 | -796,511 |
| Other shareholders' equity | 0 | 62 | -12 | -449 | -13 |
| TOTAL | $-5,951 | $17,463 | $34,306 | $53,302 | $209,824 |
| Total Liabilities And Equity | $244,220 | $234,905 | $259,122 | $165,525 | $252,790 |